Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"The Lancet. Haematology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22F0P408N6V4%22&type=Subject&filter%5B%5D=journalStr%3A%22The+Lancet.+Haematology%22
/vufind/Search/Results?lookfor=%22F0P408N6V4%22&type=Subject&filter%5B%5D=journalStr%3A%22The+Lancet.+Haematology%22
Search /vufind/Search2/Results?lookfor=%22F0P408N6V4%22&type=Subject&filter%5B%5D=journalStr%3A%22The+Lancet.+Haematology%22
PubPharm (46)
1
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma : a cohort of a multicentre, single-arm, phase 1b/2 study
enthalten in:
The Lancet. Haematology
| 2024
von
Abrisqueta, P.
|
González-Barca, E.
|
Panizo, C.
| +13
Wird geladen...
2
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial
enthalten in:
The Lancet. Haematology
| 2024
von
Mai, E.
|
Goldschmid, H.
|
Miah, K.
| +74
ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740
Wird geladen...
3
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER) : final report of the multicentre, single-arm, phase 2 trial
enthalten in:
The Lancet. Haematology
| 2023
von
Costa, L.
|
Chhabra, S.
|
Medvedova, E.
| +14
CommentIn: Lancet Haematol. 2023 Nov;10(11):e867-e868. - PMID 37776871
Wird geladen...
4
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN) : final analysis of an open-label, randomised, phase 2 trial
enthalten in:
The Lancet. Haematology
| 2023
von
Voorhees, P.
|
Sborov, D.
|
Laubach, J.
| +25
CommentIn: Lancet Haematol. 2023 Oct;10(10):e788-e789. - PMID 37793762
Wird geladen...
5
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO) : extended follow up of an open-label, randomised, multicentre, phase 3 trial
enthalten in:
The Lancet. Haematology
| 2023
von
Dimopoulos, M.
|
Terpos, E.
|
Boccadoro, M.
| +18
Wird geladen...
6
Second primary malignancies in patients with haematological cancers treated with lenalidomide : a systematic review and meta-analysis
enthalten in:
The Lancet. Haematology
| 2022
von
Saleem, K.
|
Franz, J.
|
Klem, M.
| +5
CommentIn: Lancet Haematol. 2022 Dec;9(12):e868-e869. - PMID 36457218
Wird geladen...
7
Lenalidomide and risk of second primary malignancy-is disease context key?
enthalten in:
The Lancet. Haematology
| 2022
von
Pawlyn, C.
|
Bird, S.
CommentOn: Lancet Haematol. 2022 Dec;9(12):e906-e918. - PMID 36354020
Wird geladen...
8
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
enthalten in:
The Lancet. Haematology
| 2022
von
Goldschmidt, H.
|
Mai, E.
|
Bertsch, U.
| +123
CommentIn: Lancet Haematol. 2022 Nov;9(11):e798-e799. - PMID 36328036
Wird geladen...
9
Elotuzumab : no benefit for older patients with newly diagnosed multiple myeloma
enthalten in:
The Lancet. Haematology
| 2022
von
Touzeau, C.
CommentOn: Lancet Haematol. 2022 Jun;9(6):e403-e414. - PMID 35550060
Wird geladen...
10
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1) : an open-label, multicentre, randomised, phase 3 trial
enthalten in:
The Lancet. Haematology
| 2022
von
Dimopoulos, M.
|
Richardson, P.
|
Bahlis, N.
| +124
CommentIn: Lancet Haematol. 2022 Jun;9(6):e386-e387. - PMID 35550059
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: The Lancet. Haematology
Medienart
46
Aufsätze
46
E-Artikel
46
E-Ressourcen
Zeitschriftentitel
The Lancet. Haematology
Thema
46
F0P408N6V4
46
Lenalidomide
41
Journal Article
18
7S5I7G3JQL
18
Dexamethasone
17
Multicenter Study
16
4Z8R6ORS6L
16
Thalidomide
14
Comment
14
Randomized Controlled Trial
13
Clinical Trial, Phase II
11
Antibodies, Monoclonal, Humanized
11
Clinical Trial, Phase III
9
4F4X42SYQ6
9
69G8BD63PP
9
Bortezomib
9
Rituximab
7
Clinical Trial, Phase I
6
Antineoplastic Agents
5
1351PE5UGS
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
28
2020-
18
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
46
Englisch
Haven't found what you're looking for?
Wird geladen...